BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30337175)

  • 1. Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
    Salát J; Formanová P; Huňady M; Eyer L; Palus M; Ruzek D
    Vaccine; 2018 Nov; 36(48):7257-7261. PubMed ID: 30337175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alimentary Infections by Tick-Borne Encephalitis Virus.
    Ličková M; Fumačová Havlíková S; Sláviková M; Klempa B
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First detection of tick-borne encephalitis virus (TBEV) in raw milk samples in North-Western Iran.
    Parsadanians A; Mirshahabi H; Yavarmanesh M
    Vet Med Sci; 2024 Jul; 10(4):e1477. PubMed ID: 38896036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of tick-borne encephalitis vaccination in Latvia, 2018-2020: an observational study.
    Zavadska D; Freimane Z; Karelis G; Ermina I; Harper LR; Bender C; Zhang P; Angulo FJ; Erber W; Bormane A; Gutmane E; Litauniece ZA; Tihonovs J; Griskevica A; Madhava H; Jodar L
    Clin Microbiol Infect; 2023 Nov; 29(11):1443-1448. PubMed ID: 37422077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of inactivated mature tick-borne encephalitis virus at 3.0 Å resolution.
    Pichkur EB; Vorovitch MF; Ivanova AL; Protopopova EV; Loktev VB; Osolodkin DI; Ishmukhametov AA; Samygina VR
    Emerg Microbes Infect; 2024 Dec; 13(1):2313849. PubMed ID: 38465849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of cattle to tick-borne encephalitis virus in the historical endemic zone in north-eastern France.
    Mathews-Martin L; Gonzalez G; Dheilly NM; Amaral-Moraes R; Dumarest M; Helle T; Migne C; Caillot C; Lacour SA; Pérelle S; Beck C; Metras R; Bournez L
    BMC Vet Res; 2024 May; 20(1):228. PubMed ID: 38796429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
    Yonekawa M; Watanabe T; Kogawara O; Yoshii C; Yamaji M; Aizawa M; Erber W; Ito S; Jug B; Koelch D; de Solom R; Lockhart SP
    Vaccine; 2024 May; 42(13):3180-3189. PubMed ID: 38614954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture.
    Vorovitch MF; Grishina KG; Volok VP; Chernokhaeva LL; Grishin KV; Karganova GG; Ishmukhametov AA
    Hum Vaccin Immunother; 2020 Sep; 16(9):2123-2130. PubMed ID: 32429733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural diversity of tick-borne encephalitis virus particles in the inactivated vaccine based on strain Sofjin.
    Moiseenko A; Zhang Y; Vorovitch MF; Ivanova AL; Liu Z; Osolodkin DI; Egorov AM; Ishmukhametov AA; Sokolova OS
    Emerg Microbes Infect; 2024 Dec; 13(1):2290833. PubMed ID: 38073510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope.
    Holoubek J; Salát J; Kotouček J; Kastl T; Vancová M; Huvarová I; Bednář P; Bednářová K; Růžek D; Renčiuk D; Eyer L
    Antiviral Res; 2024 Jan; 221():105767. PubMed ID: 38040199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief tale of two pioneering moments: Europe's first discovery of Tick-Borne Encephalitis (TBE) virus beyond the Soviet Union and the largest alimentary TBE outbreak in history.
    Ruzek D; Kaucka K
    Ticks Tick Borne Dis; 2024 May; 15(3):102314. PubMed ID: 38290295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG).
    Zavadska D; Anca I; André F; Bakir M; Chlibek R; Cižman M; Ivaskeviciene I; Mangarov A; Mészner Z; Pokorn M; Prymula R; Richter D; Salman N; Simurka P; Tamm E; Tešović G; Urbancikova I; Usonis V
    Hum Vaccin Immunother; 2013 Feb; 9(2):362-74. PubMed ID: 23291941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the "Correlate(s) of Protection" to tick-borne encephalitis vaccination and infection - key points and outstanding questions.
    Ackermann-Gäumann R; Lang P; Zens KD
    Front Immunol; 2024; 15():1352720. PubMed ID: 38318179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tick-borne Encephalitis Vaccines.
    Lehrer AT; Holbrook MR
    J Bioterror Biodef; 2011; 2011(Suppl 1):3. PubMed ID: 23997980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a Tick-Borne Flavivirus in Milk.
    Offerdahl DK; Clancy NG; Bloom ME
    Front Bioeng Biotechnol; 2016; 4():40. PubMed ID: 27243000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing awareness for tick-borne encephalitis virus using small ruminants as suitable sentinels: Preliminary observations.
    Bauer BU; Könenkamp L; Stöter M; Wolf A; Ganter M; Steffen I; Runge M
    One Health; 2021 Jun; 12():100227. PubMed ID: 33732862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a highly purified tick-borne encephalitis vaccine : A personal historical account.
    Heinz FX
    Wien Klin Wochenschr; 2024 Apr; 136(7-8):215-219. PubMed ID: 37391599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection.
    Kubinski M; Beicht J; Gerlach T; Aregay A; Osterhaus ADME; Tscherne A; Sutter G; Prajeeth CK; Rimmelzwaan GF
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38276677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3.
    Ma Y; Wang J; Wu Y; Zan X; Wang Y; Zhou Y; Wang T; Gong C; Meng K; Niu R; Shang Q; Wang H; Wang J; He Y; Wang W
    Vet Res; 2024 Jun; 55(1):82. PubMed ID: 38937820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein.
    Tandavanitj R; Setthapramote C; De Lorenzo G; Sanchez-Velazquez R; Clark JJ; Rocchi M; McInnes C; Kohl A; Patel AH
    Vaccine; 2024 Apr; 42(9):2429-2437. PubMed ID: 38458875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.